
Latigo Biotherapeutics, a clinical-stage biopharmaceutical company developing non-opioid pain medicines, announced the appointment of Neha Krishnamohan as Chief Financial Officer …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

